In Market Utilisation of Liraglutide Used for Weight Management in the UK: a Study in the CPRD Primary Care Database
Phase of Trial: Phase IV
Latest Information Update: 09 May 2019
Price : $35 *
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 27 Mar 2019 Planned End Date changed from 15 Jan 2019 to 15 Jul 2022.
- 27 Mar 2019 Planned primary completion date changed from 15 Jan 2019 to 15 Jul 2022.
- 16 May 2018 Status changed from not yet recruiting to recruiting.